Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolomic and Gut Microbial Biomarkers of Smoking Cessation Treatment in Long-term Drug Therapy: A Randomized Controlled Trial

NCT06803706 is registered in ClinicalTrials.gov with Sigmund Freud PrivatUniversitat as lead sponsor.

NCT NCT06803706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06803706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolomic and Gut Microbial Biomarkers of Smoking Cessation Treatment in Long-term Drug Therapy: A Randomized Controlled Trial
Lead sponsor
Sigmund Freud PrivatUniversitat
Phase
Not applicable
Overall status
Completed
Start date
May 5, 2025
Completion date
September 18, 2026
Enrollment
97 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud), healthy adult participants, nicotine addiction, substance use disorder (sud)